• Latest
  • Trending
  • All
  • News
  • Business
  • Politics
  • World
  • Tech
CanSino’s COVID-19 vaccine candidate approved for military use in China

COVID-19 vaccine race: Main candidates and where they stand

1 week ago
Trio killed in Lawaypora were involved in militancy; will present ‘concrete evidence’ to families soon: IGP

Trio killed in Lawaypora were involved in militancy; will present ‘concrete evidence’ to families soon: IGP

6 hours ago
India records 9,985 new COVID-19 cases, 279 fatalities; death toll rises to 7,745

COVID-19: India records lowest fatalities in eight months

8 hours ago
Driver among two missing, another rescued as truck rolls down into stream in J&K’s Ramban

Driver among two missing, another rescued as truck rolls down into stream in J&K’s Ramban

9 hours ago
Adbee Markaz Kamraz Elects New Body of Office Bearers

Adbee Markaz Kamraz Elects New Body of Office Bearers

9 hours ago
1048 essential supply vehicles, including fruits, vegetables, mutton moved towards Kashmir

1048 essential supply vehicles, including fruits, vegetables, mutton moved towards Kashmir

1 day ago
Fire causes minor damage to J&K Bank branch in north Kashmir

๐’๐ž๐ฏ๐ž๐ง ๐ฌ๐ก๐จ๐ฉ๐ฌ ๐ ๐ฎ๐ญ๐ญ๐ž๐ ๐ข๐ง ๐Š๐ฎ๐ฉ๐ฐ๐š๐ซ๐š ๐Ÿ๐ข๐ซ๐ž ๐ข๐ง๐œ๐ข๐๐ž๐ง๐ญ

1 day ago
COVID-19 caseload in India breaches 80-lakh mark with 49,881 new cases

126 new COVID-19 cases in J&K

1 day ago
Fire breaks out in Nawa Kadal, second such incident in a day

Fire breaks out in Nawa Kadal, second such incident in a day

1 day ago
Bureaucracy fails good governance in J&K: Altaf Bukhari

Bureaucracy fails good governance in J&K: Altaf Bukhari

1 day ago
COVID-19 vaccination drive launched in J&K, 4 thousand health workers to get shots today

COVID-19 vaccination drive launched in J&K, 4 thousand health workers to get shots today

2 days ago
Foggy morning affects life in J&K amid intense cold wave, Srinagar Freezes At Minus 8.2

Foggy morning affects life in J&K amid intense cold wave, Srinagar Freezes At Minus 8.2

2 days ago
Govt asks All Employees to attend Offices from June 6

Govt Announces โ€˜One-Timeโ€™ Relaxation For JKCCE Exams

3 days ago
  • About
  • Privacy Policy
  • Contact
Monday, January 18, 2021
0 °c
Srinagar
-2 ° Tue
-2 ° Wed
1 ° Thu
1 ° Fri
-2 ° Sat
  • Login
Kashmir Reporter
  • News
    Trio killed in Lawaypora were involved in militancy; will present ‘concrete evidence’ to families soon: IGP

    Trio killed in Lawaypora were involved in militancy; will present ‘concrete evidence’ to families soon: IGP

    Driver among two missing, another rescued as truck rolls down into stream in J&K’s Ramban

    Driver among two missing, another rescued as truck rolls down into stream in J&K’s Ramban

    Fire causes minor damage to J&K Bank branch in north Kashmir

    ๐’๐ž๐ฏ๐ž๐ง ๐ฌ๐ก๐จ๐ฉ๐ฌ ๐ ๐ฎ๐ญ๐ญ๐ž๐ ๐ข๐ง ๐Š๐ฎ๐ฉ๐ฐ๐š๐ซ๐š ๐Ÿ๐ข๐ซ๐ž ๐ข๐ง๐œ๐ข๐๐ž๐ง๐ญ

    Fire breaks out in Nawa Kadal, second such incident in a day

    Fire breaks out in Nawa Kadal, second such incident in a day

    Govt asks All Employees to attend Offices from June 6

    Govt Announces โ€˜One-Timeโ€™ Relaxation For JKCCE Exams

    One in 13 tests in Kashmir positive for coronavirus: DAK

    Covid-19 vaccine hesitancy among healthcare workers worrisome: DAK

    Bringiโ€™ outsmarts biggest brands of water, bags Indian Leadership Award-2021

    Bringiโ€™ outsmarts biggest brands of water, bags Indian Leadership Award-2021

    Freezing weather continues unabated In Kashmir

    Srinagar shivers at minus 7.6ยฐ C, dense fog affects visibility

    COVID-19 caseload in India breaches 80-lakh mark with 49,881 new cases

    First time in 7 months, J&K records no Covid death

    Musical Talent Hunt: 10 winners declared

    Musical Talent Hunt: 10 winners declared

  • Politics
  • World
  • Business
  • Opinion
  • Sports
  • COVID19
No Result
View All Result
Kashmir Reporter
No Result
View All Result
Home National

COVID-19 vaccine race: Main candidates and where they stand

by PTI
January 10, 2021
in National
5 min read
CanSino’s COVID-19 vaccine candidate approved for military use in China
47
SHARES
134
VIEWS
Share on FacebookShare on TwitterShare on WhatsApp

New Delhi, Jan 10 (PTI)ย Almost a year into the COVID-19 pandemic, about 200 vaccine candidates are in the works and 10 have been either approved by several countries or are under limited emergency use. As India prepares to launch its vaccine drive on January 16, here is a look at the options:

COVAXIN

Developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology, the indigenous vaccine has been granted emergency use authorisation in clinical trial mode’ by the Indian government.

It is an inactivated vaccine developed by chemically treating novel coronavirus samples to make them incapable of reproduction. This process leaves the viral proteins, including the spike protein of the coronavirus which it uses to enter the human cells, intact.

Given as two doses, three weeks apart, the viral proteins in the vaccine activate the immune system and prepare people for future infections with the actual infectious virus. According to Bharat Biotech, the therapeutic can be stored at room temperature for at least a week.

A study on the Phase 1/2 trial published in the preprint server medRxiv in December showed the therapeutic doesn’t cause any serious side effects. However, there has been no further data released in the public domain which could demonstrate that the vaccine is safe and effective.

“ICMR-Bharat Biotech vaccine is a killed whole-virus vaccine and there are absolutely no data available so far on its protective efficacy. I am critical of its getting approval by the authorities,” immunologist Vineeta Bal, affiliated with the National Institute of Immunology in New Delhi, told PTI.

COVISHIELD

Co-developed by the University of Oxford and British-Swedish company AstraZeneca and known as Covishield in India, the vaccine was the first on which a scientific study was published based on Phase 3 clinical trials.

It has so far been given emergency use authorization in the UK, Argentina, Mexico and India.

Scientists have engineered a version of adenoviruses that infect chimpanzees to carry the gene responsible for the spike protein of the novel coronavirus.

It requires two doses, provided four weeks apart, to produce the desired effects.

Manufactured by the Serum Institute of India, Covishield will be sold at Rs 1,000 per dose in the private market but cost the Indian government only Rs 200, said SII CEO Adar Poonawalla,

“Oxford-AstraZeneca-Serum Institute vaccine has shown protective efficacy in global trials to the tune of 60-70 per cent. While clear data from bridging trials in India are not available, the vaccine is certainly proven safe,” Bal said.

According to virologist Upasana Ray from the CSIR-Indian Institute of Chemical Biology, Kolkata, the AstraZeneca-Oxford vaccine is less restricted in terms of cold storage as it can be stored, transported and handled at normal refrigerator temperatures (2-8 degrees Celsius) for at least six months.

MODERNA

The mRNA vaccine by US-based company Moderna has so far been approved for use in Israel, the EU, Canada and the US.

A study of the efficacy of Moderna vaccine revealed it has 94.1 per cent efficacy in preventing the disease. In this type of vaccine, the messenger RNA — or mRNA — acts as a blueprint for the production of the coronavirus spike protein and is encapsulated by lipid molecules and delivered into human cells.

The cells of the vaccine recipient then use this mRNA genetic code to produce the viral protein to train the immune system for a future encounter with the infectious coronavirus.

Administered as two doses, four weeks apart, the Moderna vaccine can reportedly be stored in the refrigerator at 2-8 degrees Celsius for up to 30 days. At -20 degrees Celsius it can be stored for up to six months. This is still a challenge for many developing countries in the tropical regions that experience very high temperatures in the summer months.

In November last year, Moderna Chief Executive Stephane Bancel told a German weekly that the company would charge governments between USD 25 and 37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered.

PFIZER-BIONTECH

The US-backed Pfizer-Biontech’s COVID-19 preventive, like the Moderna vaccine, is based on the segments of the genetic material of the novel coronavirus. Preliminary data from the clinical trials showed that two doses of the vaccine, given three weeks apart, provided an efficacy of over 90 per cent.

Following the results, the UK, Canada, the EU and Saudi Arabia have approved the Pfizer vaccine for use. Several countries, including the US, Singapore, Argentina and Mexico, have given emergency use authorisation.

One limitation for the Pfizer vaccine has been its requirement for ultracold storage — up to -70 degrees Celsius.

Each dose is reportedly priced at USD 37.

SPUTNIK V

Sputnik V from Russia’s Gamaleya Research Institute has been approved for emergency use by several countries but awaits more results from Phase 3 trials.

An adenovirus vectored vaccine, Sputnik V is produced using a combination of two adenoviruses called Ad5 and Ad26. Preliminary evidence from Phase 3 trials indicates it is 90 per cent effective when given as two doses, three weeks apart.

In November, the Russian Direct Investment Fund said the cost of the vaccine would be less than USD 10 per dose starting from February 2021. It said the dry form of the vaccine can be stored at 2-8 degrees Celsius, and does not need freeze storage.

CONVIDECIA

The adenovirus vectored vaccine developed by the Chinese company CanSino Biologics is also under Phase 3 trials and has already been approved for limited use by the Chinese military.

Since August, the vaccine has been part of Phase 3 trials in several countries, including Russia, Mexico and Pakistan.

CORONAVAC

Another Chinese company, Sinopharm, has also made progress with its inactivated vaccine dubbed CoronaVac. It has been given emergency approval for limited use in the country. The vaccine is reportedly provided as two doses, administered two weeks apart. Scientists are yet to publish a study on the trial conducted so far.

VECTOR INSTITUTE

Russia’s Vector Institute has developed a protein vaccine. It is currently under Phase 3 clinical trials. It uses modified versions of the coronavirus spike protein to induce immunity. The vaccine reportedly can be stored at 2-8 degrees celsius for up to two years. Data on the efficacy of the therapeutic is yet to be released.

NOVAVAX

After showing promising results in Phase 1-2 trials, and in animal experiments, the vaccine developed by US company Novavax is currently under Phase 3 clinical trials. It uses modified versions of the coronavirus spike protein to induce immunity, and can reportedly be stored at 2-8 degrees Celsius. After some setbacks in manufacturing the doses required for the Phase 3 study in the US, the trial was finally launched on December 28.

JOHNSON & JOHNSON

The adenovirus vectored vaccine by the American company has shown protection against the coronavirus in experiments in monkeys and is currently part of Phase 3 clinical trials. Unlike other vaccines, this vaccine is reportedly provided as a single dose, but trials are currently underway to test its efficacy as two doses. The company had noted that the therapeutic can be stored for up to three months when refrigerated at 2-8 degrees Celsius, and up to two years when frozen at -20 degrees Celsius.

Share19Tweet12Send
  • Trending
  • Comments
  • Latest
Pakistani cricketer Shahid Afridi visits Hindu temple with food supply amidst COVID-19 pandemic; Yuvraj Singh had supported his initiative

Pakistani cricketer Shahid Afridi visits Hindu temple with food supply amidst COVID-19 pandemic; Yuvraj Singh had supported his initiative

May 13, 2020
Meet Ustaz Nafis Yaakub, the boy who used to recite the Quran in prison!

Meet Ustaz Nafis Yaakub, the boy who used to recite the Quran in prison!

May 16, 2020
MGNREGA supporting staff awaits absorption โ€˜Following a proper mechanism: Advisor

MGNREGA supporting staff awaits absorption โ€˜Following a proper mechanism: Advisor

June 27, 2020
Trio killed in Lawaypora were involved in militancy; will present ‘concrete evidence’ to families soon: IGP

Trio killed in Lawaypora were involved in militancy; will present ‘concrete evidence’ to families soon: IGP

All traders from Magarmal Bagh stage protest against administration, demands rehabilitation.

All traders from Magarmal Bagh stage protest against administration, demands rehabilitation.

JK students dominate in Aryans Chandigarh Academic results

JK students dominate in Aryans Chandigarh Academic results

Trio killed in Lawaypora were involved in militancy; will present ‘concrete evidence’ to families soon: IGP

Trio killed in Lawaypora were involved in militancy; will present ‘concrete evidence’ to families soon: IGP

January 18, 2021
India records 9,985 new COVID-19 cases, 279 fatalities; death toll rises to 7,745

COVID-19: India records lowest fatalities in eight months

January 18, 2021
Driver among two missing, another rescued as truck rolls down into stream in J&K’s Ramban

Driver among two missing, another rescued as truck rolls down into stream in J&K’s Ramban

January 18, 2021
Kashmir Reporter

ยฉ 2020 Kashmir Reporter.

Navigate Site

  • About
  • Privacy Policy
  • Contact

Follow Us

No Result
View All Result
  • Home
  • COVID19
  • News
  • Politics
  • World
  • Opinion
  • Business
  • Sports

ยฉ 2020 Kashmir Reporter.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.